Mercer Global Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Mercer Global Advisors's CRL Position: Q3 2026 in Review
Mercer Global Advisors increased its Charles River Laboratories (CRL) stake by 2.4% in Q3 2026, buying an estimated $44.3K and bringing the position to 7,243 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1376.
Mercer Global Advisors first reported a position in CRL in Q1 2021 and has held it in 23 quarters since. 644 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Mercer Global Advisors held 7,243 shares of Charles River Laboratories worth $2.14M as of Q3 2026.
- Mercer Global Advisors bought 168 Charles River Laboratories shares in Q3 2026, an estimated $44.3K.
- Charles River Laboratories made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #1376 holding.
- Mercer Global Advisors first reported a position in Charles River Laboratories in Q1 2021 and has held it in 23 quarters since.
- 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.